| Jan 9, 2015
| 7:20 AM
Express Scripts, which handles prescription-drug benefits for millions of people nationwide, is dropping coverage for 66 brand-name drugs in January in an effort to keep costs down. Rival CVS Health is dropping 95 drugs from its own list of covered drugs....
| Jan 5, 2015
| 2:16 PM
CVS Health announced Monday that it plans to make Gilead Sciences' hepatitis C drugs the exclusive option for most of its consumers starting Wednesday.
The announcement comes two weeks after Express Scripts, the nation's largest manager of prescription...
| Sep 23, 2014
| 1:30 PM
An American doctor who is recovering from Ebola at a Nebraska hospital got an experimental Canadian drug as part of his treatment, hospital officials disclosed this week.
Dr. Rick Sacra started receiving TKM-Ebola, manufactured by Canadian drug firm ...
| Sep 9, 2014
| 12:09 PM
Botox maker Allergan Inc. of Irvine appears increasingly likely to be acquired by a Canadian rival, an analyst said Tuesday.
Valeant Pharmaceuticals International Inc. has been working for five months to acquire Allergan and its coveted lineup of beauty...
| Nov 15, 2014
| 10:11 PM
The company at the center of a probe into why more than a dozen women died after being sterilized in India has denied that the antibiotic tablets it manufactured were contaminated with a chemical compound commonly found in rat poison.
| Oct 8, 2014
| 3:47 AM
According to a new federal database put online last week, pharmaceutical companies and device makers paid doctors some $380 million in speaking and consulting fees over a five-month period in 2013.
Some doctors received over $500,000 each, and some...
| Oct 8, 2014
| 10:28 AM
Shares of Chimerix Inc., the maker of an experimental drug to combat Ebola, sank Wednesday after the death in Dallas of a patient with the disease who received the medicine.
About two hours after officials announced the death of Thomas Eric Duncan,...
| Oct 27, 2014
| 5:10 PM
As shareholders of Botox maker Allergan Inc. prepare for a vote on the company's future, a Canadian suitor said it's willing to increase its offer to buy the Irvine firm.
J. Michael Pearson, chief executive of Valeant Pharmaceuticals International Inc.,...
| Dec 18, 2014
| 1:34 PM
A new lawsuit accuses hedge fund manager Bill Ackman and Canadian firm Valeant Pharmaceuticals International Inc. of insider trading in Allergan Inc. stock before their unsuccessful bid to acquire the Botox maker.
The lawsuit was filed Wednesday on...
| Aug 8, 2014
| 1:46 PM
After several months as a customer of NuScriptRX, a 4-year-old pharmacy management company based in Nashville, Tenn., Sentara Healthcare has purchased a 12 percent share in the company.
The company has developed a fully automated on-site medication...
| Oct 12, 2014
| 5:00 AM
While much of the nation is preoccupied with Obamacare and picking new health insurance at work, older Americans have deadlines of their own coming up — involving Medicare.
We're just a few days away from the two-month period when the nation's...